Injectable Protein Shows Promise in Repairing “Leaky Gut” and Alleviating Depression
Table of Contents
A groundbreaking new study suggests a potential future where a single injection could simultaneously address both gastrointestinal distress and severe depression. Researchers at the University of Victoria (UVic) have identified a glycoprotein called Reelin as a key factor in restoring gut health and reducing symptoms associated with major depressive disorder (MDD).
The research, published in the journal Chronic stress, offers a novel approach to tackling these frequently enough-co-occurring conditions by targeting the intricate connection between the gut and the brain.
The Vicious Cycle of Stress, Gut health, and Depression
In a healthy body, the gastrointestinal system – encompassing the stomach, colon, and intestines – meticulously regulates the passage of nutrients into the bloodstream. However, chronic stress, a pervasive issue in modern life, can disrupt this delicate balance. Over time, this disruption can led to a condition commonly known as “leaky gut,” where the gut barrier becomes overly permeable.
When the gut barrier weakens, harmful bacteria and toxins can escape into the circulation, triggering an immune response and subsequent inflammation. This inflammation, in turn, is increasingly recognized as a significant contributor to the development and exacerbation of depressive symptoms. Treatments focused on strengthening the gut barrier, therefore, represent a promising avenue for mitigating the risk and severity of MDD.
Reelin: A Potential Bridge Between Gut and Brain
According to researchers, therapies centered around Reelin may offer a dual-action solution for both gut and brain health.Reelin is a protein naturally found throughout the body, including in the brain, blood, liver, and intestines.
“This study aimed to understand the role of Reelin in the gut, especially under conditions of chronic stress,” explained a senior researcher involved in the study. “The gut-brain axis is becoming essential to understanding many psychiatric disorders, including depression.”
Preclinical models revealed that chronic stress significantly reduced Reelin levels in the intestines. Remarkably, a single injection of just 3 µg of Reelin was sufficient to restore those levels to normal.
Restoring Gut Lining and Reducing Depressive Symptoms
Previous research has consistently demonstrated lower levels of Reelin in the brains of individuals diagnosed with major depressive disorder. Similar reductions have been observed in rodents subjected to chronic stress. In these animal models, a single intravenous injection of 3 µg of reelin exhibited antidepressant-like effects. Furthermore, prior work has established that Reelin is crucial for the healthy renewal of the gut lining.
“Taken together, these results may have vital implications for the management of major depressive disorder,” stated a lead researcher on the project. “This is especially true for people who live with both depression and gastrointestinal conditions.”
The gut lining is constantly being renewed,with cells replaced every four to five days,a critical process given its constant exposure to perhaps damaging substances. If Reelin effectively protects against leaky gut by supporting this renewal process, it could, in turn, protect against the worsening of depression symptoms triggered by inflammatory immune responses to leaked gut material.
Looking Ahead: A New Approach to Mental Health
While further research is necessary before Reelin-based treatments can be implemented in clinical practice, the findings represent a significant step forward. By simultaneously targeting both the brain and the gut, Reelin could ultimately provide a more holistic and effective approach to treating depression.
The study received financial support from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC).
